| P2093 | author name string | K F Frank | |
| | R H G Schwinger | |
| | C Mei | |
| | H Diedrichs | |
| | B Boelck | |
| P2860 | cites work | Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload | Q73143259 |
| | Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy | Q73267718 |
| | Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats | Q73645352 |
| | GATA4: a novel transcriptional regulator of cardiac hypertrophy? | Q73951488 |
| | cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction | Q73951513 |
| | Involvement of calcineurin in angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibroblast hyperplasia of rats | Q74019951 |
| | Signaling path may lead to better heart-failure therapies | Q74516567 |
| | Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats | Q77215433 |
| | Calcineurin inhibitors and cardiac hypertrophy | Q77407799 |
| | Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium | Q77912853 |
| | Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3 | Q24309262 |
| | Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases | Q24537383 |
| | The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes | Q24548283 |
| | Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload | Q24654964 |
| | A calcineurin-dependent transcriptional pathway for cardiac hypertrophy | Q28269300 |
| | Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy | Q28343890 |
| | Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene | Q28566172 |
| | Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study | Q29614968 |
| | Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype? | Q33585721 |
| | Signaling in myocardial hypertrophy: life after calcineurin? | Q33585726 |
| | Trends of congestive heart failure epidemiology: contrast with clinical trial results | Q33802921 |
| | Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo | Q34727513 |
| | The role of modulatory calcineurin-interacting proteins in calcineurin signaling | Q35055274 |
| | The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects | Q41059187 |
| | Factors involved in cardiogenesis and the regulation of cardiac-specific gene expression | Q41222660 |
| | The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. | Q42504443 |
| | Angiotensin II induced cardiac hypertrophy in vivo is inhibited by cyclosporin A in adult rats | Q43840391 |
| | Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats | Q44703364 |
| | Unchanged sarcoplasmic reticulum Ca2+-ATPase activity, reduced Ca2+ sensitivity, and negative force-frequency relationship in transgenic rats overexpressing the mouse renin gene | Q47861945 |
| | Effect of the Na+-channel modulator BDF 9148 on Ca2+-sensitivity and force of contraction of hypertrophic myocardium from transgene rats harboring the mouse Renin gene (TG(mREN2)27). | Q47894616 |
| | Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure | Q47973168 |
| | Angiotensin II-Induced Ventricular Hypertrophy and Extracellular Signal-Regulated Kinase Activation Are Suppressed in Mice Overexpressing Brain Natriuretic Peptide in Circulation | Q48144427 |
| | Calcineurin and human heart failure | Q56877814 |
| | Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions | Q56963807 |
| | Ontogenetic regulation of mouse Ren-2d renin gene in transgenic hypertensive rats, TGR(mREN2)27 | Q56963870 |
| | Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure | Q57396530 |
| | Prevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition | Q57396540 |
| | Pressure Overload Induces Severe Hypertrophy in Mice Treated With Cyclosporine, an Inhibitor of Calcineurin | Q60425260 |
| | Revisiting calcineurin and human heart failure | Q62397376 |
| | Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure | Q67486128 |
| | Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model | Q68136822 |
| | Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure | Q69122833 |
| | Unchanged Protein Levels of SERCA II and Phospholamban but Reduced Ca 2+ Uptake and Ca 2+ -ATPase Activity of Cardiac Sarcoplasmic Reticulum From Dilated Cardiomyopathy Patients Compared With Patients With Nonfailing Hearts | Q71807622 |
| | A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues | Q72426100 |
| | Comparison of number of extrastimuli versus change in basic cycle length for induction of ventricular tachycardia by programmed ventricular stimulation | Q72573772 |
| P433 | issue | 10 | |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 688-695 | |
| P577 | publication date | 2004-08-20 | |
| P1433 | published in | Journal of Molecular Medicine | Q6295593 |
| P1476 | title | Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27. | |
| P478 | volume | 82 | |